Analysis of the association of sugammadex with the length of hospital stay in patients undergoing abdominal surgery: a retrospective study

Analysis of the association of sugammadex with the length of hospital stay in patients undergoing abdominal surgery: a retrospective study

Abstract Background Sugammadex is a newer medication used for rapid and reliable reversal of neuromuscular blockade. This study evaluated whether sugammadex could reduce the length of postoperative hospital stay in patients undergoing abdominal surgery. Methods This single center retrospective cohor...

Full description

Bibliographic Details
Main Authors:	Jing Tan, Jianhua He, Lijun Wang, Jia Fang, Pengyi Li, Zhenghuan Song, Qingming Bian
Format:	Article
Language:	English
Published:	BMC 2023-01-01
Series:	BMC Anesthesiology
Subjects:	Sugammadex Postoperative hospital stay Reversal agents Neuromuscular blockade
Online Access:	https://doi.org/10.1186/s12871-023-01979-4

Similar Items

Comparison of the effects of sugammadex and neostigmine on hospital stay in robot-assisted laparoscopic prostatectomy: a retrospective study
by: Byung-Hun Min, et al.
Published: (2020-07-01)

Comparative study between sugammadex and neostigmine in neurosurgical anesthesia in pediatric patients
by: Ayman A Ghoneim, et al.
Published: (2015-01-01)

Sugammadex in Emergency Situations
by: Cyrus Motamed
Published: (2023-01-01)

Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports
by: Usha Gurunathan, et al.
Published: (2019-11-01)

Failure of reversion of neuromuscular block with sugammadex in patient with myasthenia gravis: case report and brief review of literature
by: Hermann dos Santos Fernandes, et al.
Published: (2019-08-01)

Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy
by: Marie T. Aouad, et al.
Published: (2017-04-01)

The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade
by: Soon Ho Cheong, et al.
Published: (2015-12-01)

A Meta-Analysis on the Effect of Dexamethasone on the Sugammadex Reversal of Rocuronium-Induced Neuromuscular Block
by: Chang-Hoon Koo, et al.
Published: (2020-04-01)

Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center
by: Carron M, et al.
Published: (2016-02-01)

Advantages and pitfalls of clinical application of sugammadex
by: Hyung Young Lee, et al.
Published: (2020-07-01)

Effects of hydrocortisone-presensitized sugammadex on recovery from neuromuscular blockade induced by rocuronium: a rodent in vivo study
by: Hey-Ran Choi, et al.
Published: (2022-04-01)

Effects of different sugammadex doses on the train of four ratio recovery progression during rocuronium induced neuromuscular blockade in the rat phrenic nerve hemidiaphragm
by: Yong Beom Kim, et al.
Published: (2020-06-01)

Myasthenia gravis and sugammadex: A case report and review of the literature
by: Sujana Dontukurthy, et al.
Published: (2020-01-01)

Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial
by: Tom Schepens, et al.
Published: (2019-10-01)

Effects of age on sugammadex reversal of neuromuscular blockade induced by rocuronium in Chinese children: a prospective pilot trial
by: Ruidong Zhang, et al.
Published: (2021-10-01)

Initial experience with the unrestricted introduction of sugammadex at a large academic medical center: a retrospective observational study examining postoperative mechanical ventilation and efficiency outcomes
by: Vikas N. O’Reilly-Shah, et al.
Published: (2018-10-01)

Effects of sevoflurane and adenosine receptor antagonist on the sugammadex‐induced recovery from rocuronium‐induced neuromuscular blockade in rodent phrenic nerve–hemidiaphragm tissue specimens
by: Yong Beom Kim, et al.
Published: (2021-08-01)

Sugammadex: clinical development and practical use
by: Thomas Fuchs-Buder, et al.
Published: (2013-12-01)

Sugammadex, neostigmine and postoperative pulmonary complications: an international randomised feasibility and pilot trial
by: Kate Leslie, et al.
Published: (2021-11-01)

An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant
by: Stephania Paredes, et al.
Published: (2023-03-01)

Decurarization After Thoracic Anesthesia using sugammadex compared to neostigmine (DATA trial): a multicenter randomized double-blinded controlled trial
by: Federico Piccioni, et al.
Published: (2024-02-01)

Sugammadex-associated asystole in young obese patient: Case report
by: Steven J. Lohmeier, et al.
Published: (2022-09-01)

Sugammadex to reverse residual neuromuscular blockade and facilitate neurologic examination in an adolescent trauma patient in the Pediatric ICU setting.
by: T. Renner, et al.
Published: (2023-07-01)

Effects of hyperthermia on the effective concentration of rocuronium and sugammadex-mediated reversal in isolated phrenic nerve hemidiaphragm preparations of rats
by: Jin Sun Kim, et al.
Published: (2020-08-01)

Sugammadex reversal of muscle relaxant blockade provided less Post-Anesthesia Care Unit adverse effects than neostigmine/glycopyrrolate
by: Hsiao-Cheng Chang, et al.
Published: (2022-12-01)

Chronic exposure to dexamethasone may not affect sugammadex reversal of rocuronium-induced neuromuscular blockade: an in vivo study on rats
by: Ha Yeon Park, et al.
Published: (2023-07-01)

Choice of neuromuscular block reversal agent to reduce postoperative pulmonary complications
by: Sung-Ae Cho, et al.
Published: (2022-04-01)

Sugammadex administration in pregnant patients undergoing non-obstetric surgery: a case series
by: Sara Martins Torres, et al.
Published: (2022-07-01)

Retrospective study on sugammadex for reversal of neuromuscular blockade after radiofrequency ablation of hepatic carcinoma under general anesthesia
by: ZHANG Hui, GONG Ling, GUO Qian, LUO Yan
Published: (2023-01-01)

Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
by: Tiffany Woo, et al.
Published: (2013-12-01)

Economic analysis of sugammadex versus neostigmine for reversal of neuromuscular blockade for laparoscopic surgery in China
by: Maodong Ren, et al.
Published: (2020-11-01)

Effects of Neostigmine and Sugammadex for Reversal of Neuromuscular Blockade on QT Dispersion Under Propofol Anesthesia: A Randomized Controlled Trial
by: Yusuke Yamashita, et al.
Published: (2018-09-01)

Sugammadex versus neostigmine for neuromuscular blockade reversal in outpatient surgeries: A randomized controlled trial to evaluate efficacy and associated healthcare cost in an academic center
by: Juan Fiorda Diaz, et al.
Published: (2022-12-01)

Effects of Sugammadex and Neostigmine on Post-operative Nausea and Vomiting in ENT Surgery
by: Nik Izyan Syaizana Nik Mat, et al.
Published: (2022-05-01)

Sugammadex and blood loss during cervical spine fusion surgery
by: Ryan J Keneally, et al.
Published: (2023-01-01)

Preparing for the unexpected: special considerations and complications after sugammadex administration
by: Hajime Iwasaki, et al.
Published: (2017-10-01)

Efficacy and safety of sugammadex for neuromuscular blockade reversal in pediatric patients: an updated meta-analysis of randomized controlled trials with trial sequential analysis
by: Bingchen Lang, et al.
Published: (2022-05-01)

Reversal of neuromuscular block with sugammadex in five heart transplant pediatric recipients
by: Ricardo Vieira Carlos, et al.
Published: (2018-08-01)

Sugammadex to reverse neuromuscular blockade and provide optimal conditions for motor-evoked potential monitoring
by: Mehdi Trifa, et al.
Published: (2017-01-01)

Impact of Neostigmine and Sugammadex on Time to Leaving the Operating Room in a Community Hospital
by: Julie John, et al.
Published: (2020-08-01)